
    
      The study will initiate (Part 1) with participants with severe impaired renal function
      (Cohort 1) and their matched healthy control participants (Cohort 4). Following data review,
      the study may proceed (Part 2) with participants with moderate (Cohort 2) and mild (Cohort 3)
      impaired renal function if deemed necessary.
    
  